Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Three Reasons to Sell MAKO Surgical Corp. (MAKO) Today

Page 1 of 2

I’m going to attempt something a little odd today, Fools. Even though MAKO Surgical Corp. (NASDAQ:MAKO) stock makes up just less than 1% of my real-life holdings, I’m going to be giving you three reasons to consider selling the stock today.

MAKO Surgical Corp. (NASDAQ:MAKO)

Why am I doing this?

Recently, Nobel Prize winner Daniel Kahneman visited Fool headquarters in Virginia. While visiting, he talked about how a number of different biases can lead us to believe we can predict the future with relative certainty. In reality, he argued, we are just deluding ourselves.

It got me to thinking about how I don’t write enough about the risks of owning the stocks I own. So, though I don’t plan on selling my MAKO stock right now, I think it’s healthy for me to practice and model this behavior.

1. Management doesn’t have a good idea of what’s going on
One of the biggest reasons why MAKO Surgical Corp. (NASDAQ:MAKO)’s stock sits 70% lower today than it did in March 2012 is that management has not been able to get an accurate read on how its product will sell. This led to overly optimistic predictions that sent shares as high as $43.75. Today, MAKO Surgical Corp. (NASDAQ:MAKO) trades hands at about $12.30.

The trouble started in May 2012, when management announced that sales of the company’s RIO system — which helps perform hip and knee replacements — came in at only six units. Revenue missed even the company’s low-end projections.

To the frustration of investors, those overly optimistic projections continued. In July, the company announced the sale of only nine RIO systems. It’s not a good sign when management seems that out of touch with its product’s realistic potential.

2. There’s no guarantee MAKOplasty will catch on
MAKOplasty is the name given to the procedure that the company’s RIO robotic system can perform for partial knee and total hip replacement.

Source: MAKO Surgical.

Many investors — including myself — were quick to point out that MAKO Surgical Corp. (NASDAQ:MAKO) was a lot like fellow robotic surgical company Intuitive Surgical, Inc. (NASDAQ:ISRG). Intuitive Surgical, Inc. (NASDAQ:ISRG)’s da Vinci robot has become a standard in hospitals around the world for performing prostatectomies and hysterectomies. It is also being explored for a variety of other potential surgical operations. Since March 2003, Intuitive Surgical, Inc. (NASDAQ:ISRG)’s stock has returned more than 6,500%!

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!